CONDENSED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	3 Months Ended		85 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Operating activities
Net loss	$ (465,278)	$ (418,577)	$ (8,488,538)
Adjustments to reconcile net income to net cash provided (used) by operating activities
Depreciation	8,496	8,496	210,678
Change in allowance for uncollectible note receivable			38,867
Amortization of deferred financing costs			59,605
Loss on extinguishment of debt			381,113
Write-off of uncollectible deposits			20,000
Accrued interest on note receivable			(11,705)
Loss on impairment			42,800
Amortization of beneficial conversion feature of the notes payable		(65,264)	789,216
Common stock issued for services	83,745	690,180	3,065,140
Common stock issued for legal services	7,683	51,199	130,106
Common stock issued for financing fees			5,000
Decrease (increase) in:
Prepaid expenses	11,362	(426,160)	(27,708)
Advances to shareholders	(1,542)		(2,557)
Deposits and other receivables			(23,346)
Accounts payable and accrued expenses	(140)	(8,358)	234,374
Net cash provided (used) by operating activities	(204,746)	(168,484)	(3,576,955)
Cash flows from investing activities:
Principal payments from notes receivable			(25,000)
Purchase of common stock			(34,100)
Property and equipment acquisitions			(325,000)
Net cash provided (used) by investing activities			(384,100)
Cash flows from financing activities:
Proceeds from the issuance of common stock	105,250	151,845	2,431,137
Proceeds from the issuance of convertible notes payable	126,505	79,000	1,192,305
Proceeds from the issuance of convertible notes payable, related parties		55,500	200,000
Proceeds from issuance of notes payable			286,500
Proceeds from issuance of notes payable, related parties			8,500
Payments on convertible notes payable		(30,000)	(76,000)
Payments on notes payable			(57,500)
Payments on notes payable, related parties			(1,000)
Proceeds from loans from stockholders			49,675
Payments on loans from stockholders			(44,975)
Net cash provided by financing activities	231,755	256,345	3,988,642
Net increase (decrease) in cash	27,009	87,861	27,587
Cash - beginning	578	43,919
Cash - ending	27,587	131,780	27,587
Supplemental disclosure of cash flow information:
Cash paid for interest expense			3,660
Cash paid for income taxes
Noncash operating and financing activities:
Due to Organetix, Inc. reclassified to additional paid-in capital			91,500
Common stock issued in connection with a joint venture			9,800
Common stock issued to satisfy debt	7,683		140,870
Common stock issued to satisfy minimum value guaranteed			87,667
Convertible debt converted and accrued interest to common stock	61,400		1,571,000
Common stock issued in exchange for property and equipment			$ 7,420